Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
NCT03438682 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 89203
Last updated 2021-11-03
Summary
More than 345,000 U.S. women undergo either tubal ligation ("getting her tubes tied") or Essure procedures each year to permanently avoid pregnancy. Both prevent pregnancy by blocking women's Fallopian tubes but neither are 100% effective. Both can have complications, but not enough is known to help women make an informed choice between the two.
Essure is popular because it can be performed without anesthesia in a doctor's office and women can return to work the next day. However, patients have reported that the Essure procedure was unexpectedly painful. Also, women need to use other contraceptives for 3 months and then return for testing, to make sure their tubes are blocked and will prevent pregnancy. Not all women return for this test and some may get pregnant before realizing their Essure didn't work.
Essure was approved by the Food and Drug Administration (FDA) in 2002, but no studies ever compared it to tubal ligation. By 2015, over 9,000 women reported serious complications to the FDA. Women who were unhappy with Essure found each other online and created a Facebook "Essure Problems" support group that now has over 31,000 members. After an FDA Advisory Board expressed concerns about Essure's risks, in 2016 the FDA required stronger warnings about complications and announced that "more rigorous research" was needed, demanding Essure's maker conduct a new study comparing the benefits and risks of Essure to tubal ligation. Unfortunately, that study will not be finished before September 2023.
To provide answers as rapidly as possible for women considering sterilization, we will analyze data from the medical records of thousands of women with sterilization procedures funded by California's Medicaid. As poor women and women of color have different experiences with healthcare, and they more often choose sterilization, comparing these women's experiences with Essure and tubal ligation is very important. We will compare the safety and effectiveness of the 2 sterilization procedures to answer:
* How many women got pregnant afterwards?
* How many operations did each woman need to become infertile?
* Which complications did women have (i.e. chronic pain, depression)? We will also check whether certain women (such as certain age groups or those with diabetes) were most likely to have problems after either procedure.
Conditions
- Sterility, Female
- Contraception
- Contraceptive Device; Complications
Interventions
- DEVICE
-
Essure
Essure hysteroscopic sterilization
- PROCEDURE
-
Laparoscopic sterilization
Laparoscopic sterilization via electrocautery, ring, or clip.
- DEVICE
-
Intrauterine Device (IUD)
Intrauterine Device (IUD)
Sponsors & Collaborators
-
University of California, Davis
collaborator OTHER -
National Center for Health Research
collaborator UNKNOWN -
Patient-Centered Outcomes Research Institute
collaborator OTHER -
Food and Drug Administration (FDA)
collaborator FED -
Yale University
lead OTHER
Principal Investigators
-
Aileen Gariepy, MD · Yale University
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-09-30
- Primary Completion
- 2021-07-31
- Completion
- 2021-07-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Retrospective Claims Analysis of Hysterectomy After Sterilization
NCT02527278 ·Status: COMPLETED
-
Hysteroscopic Evaluation of Fallopian Tubal Patency
NCT04077242 ·Status: COMPLETED ·Phase: NA
-
Characterization of the Essure System Tubal Sterilization Using Ultrasound and X-Ray
NCT00588497 ·Status: COMPLETED
-
Effect of Salpingectomy During Conservative Hysterectomy
NCT01628432 ·Status: COMPLETED ·Phase: NA
-
Expedited Interval Tubal Scheduling
NCT02875483 ·Status: COMPLETED ·Phase: NA
-
Laparoscopic Supracervical Hysterectomy Versus Total Laparoscopic Hysterectomy
NCT00734812 ·Status: WITHDRAWN ·Phase: PHASE3
-
Cohort Study of Risk Reducing Salpingectomy
NCT02165709 ·Status: COMPLETED ·Phase: NA
-
Chromotubation on the Remaining Fallopian Tube After a Laparoscopic Salpingectomy Due to Tubal Pregnancy
NCT06554964 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Quality of Life After Laparoscopic Removal of Essure®
NCT03281564 ·Status: COMPLETED
-
Laparoscopic Tubal Disconnection Versus Laparoscopic Salpingectomy in Infertile Patients
NCT06015698 ·Status: UNKNOWN ·Phase: NA
-
Dysfunctional Uterine Bleeding After Tubal Sterilization
NCT04396483 ·Status: RECRUITING ·Phase: NA
-
Comparison Between 2 Techniques for Bilateral Salpingectomy
NCT03788421 ·Status: COMPLETED ·Phase: NA
-
vNOTES Salpingo-oophorectomy or Bilateral Salpingectomy Compared With Laparoscopic.
NCT05228938 ·Status: TERMINATED ·Phase: NA
-
Comparison of Results of Different Surgical Techniques Used in Female Tubal Sterilization
NCT04332120 ·Status: COMPLETED ·Phase: NA
-
Assessment of Women's Sexual Quality of Life After Benign Adnexal Surgery Using vNOTES Approach
NCT05761275 ·Status: RECRUITING ·Phase: NA
-
A Randomized Study Comparing Subtotal vs Total Hysterectomy Long Term Outcomes
NCT06802198 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
SALpingectomy for STERilization (SALSTER)
NCT03860805 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery
NCT03028623 ·Status: COMPLETED ·Phase: NA
-
Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy
NCT02065453 ·Status: COMPLETED ·Phase: NA
-
vNOTES Transvaginal Endoscopic Surgery Versus Laparoscopy
NCT04324034 ·Status: RECRUITING ·Phase: NA
-
Postoperative Bladder Testing After Total Laparoscopic Hysterectomy
NCT03126162 ·Status: COMPLETED ·Phase: NA
-
Surgical Approach to Uterine Septum
NCT06315582 ·Status: RECRUITING ·Phase: NA
-
Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy
NCT00746018 ·Status: COMPLETED ·Phase: NA
-
Impact of Opportunistic Salpingectomy on Ovarian Reserve in Patients Undergoing Laparoscopic Hysterectomy
NCT01893086 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial Comparing Conventional and Robot-assisted(Da Vinci®)Laparoscopic Interventions for Hysterectomy
NCT00683293 ·Status: COMPLETED ·Phase: NA